Mice expressing a neutrophil elastase mutation derived from patients with severe congenital neutropenia have normal granulopoiesis

Blood

Volumn 100, Issue 9, 2002, Pages 3221-3228

  Grenda, David S ^a   Johnson, Sonja E ^a   Mayer, Jill R ^b   McLemore, Morgan L ^b   Benson, Kathleen F ^a   Horwitz, Marshall ^a   Link, Daniel C ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Division of Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOKINE; LEUKOCYTE ELASTASE; MESSENGER RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD ANALYSIS; BONE MARROW SUPPRESSION; CELL DIFFERENTIATION; CONGENITAL DISORDER; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GERM LINE; GRANULOCYTE; GRANULOPOIESIS; HETEROZYGOTE; HIGH RISK POPULATION; HOMOZYGOTE; MOUSE; NEUTROPENIA; NONHUMAN; NUCLEOTIDE SEQUENCE; OSCILLATION; PHENOTYPE; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN EXPRESSION; RISK FACTOR; SITE DIRECTED MUTAGENESIS; TRANSGENIC MOUSE;

EID: 0036839563     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-05-1372     Document Type: Article

References (53)

1. Kostmann R. Infantile genetic agranulocytosis: A new recessive leihal disease in man. Acta Paediatr. 1956;105:1-78.
2. Briars GL, Parry HF, Ansari BM. Dominantly inherited severe congenital neutropenia. J Infect. 1996;33:123-126.
3. Devriendt K, Kim AS, Mathijs G, et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet. 2001;27:313-317.
4. Haurie C, Dale DC, Mackey MC. Cyclical neutropenia and other periodic hematological disorders: A review of mechanisms and mathematical models. Blood. 1998;92:2629-2640.
5. Haurie C, Dale DC, Mackey MC. Occurrence of periodic oscillations in the differential blood counts of congenital, idiopathic, and cyclical neutropenic patients before and during treatment with G-CSF. Exp Hematol. 1999;27:401-409.
6. Freedman MH, Bonilla MA, Fier C, et al. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood. 2000;96:429-436.
7. Zeidler C, Welte K, Barak Y, et al. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood. 2000;95:1195-1198.
8. Welte K, Dale D. Pathophysiology and treatment of severe chronic neutropenia. Ann Hematol. 1996;72:158-165.
9. Hestdal K, Welte K, Lie SO, Keller JR, Ruscetti FW, Abrahamsen TG. Severe congenital neutropenia: Abnormal growth and differentiation of myeloid progenitors to granulocyte colony-stimulating factor (G-CSF) but normal response to G-CSF plus stem cell factor. Blood. 1993;82: 2991-2997.
10. Kobayashi M, Yumiba C, Kawaguchi Y, et al. Abnormal responses of myeloid progenitor cells to recombinant human colony-stimulating factors in congenital neutropenia. Blood. 1990;75:2143-2149.
11. Konishi N, Kobayashi M, Miyagawa S, Sato T, Katoh O, Ueda K. Defective proliferation of primitive myeloid progenitor cells in patients with severe congenital neutropenia. Blood. 1999;94: 4077-4083.
12. Nakamura K, Kobayashi M, Konishi N, et al. Abnormalities of primitive myeloid progenitor cells expressing granulocyte, colony-stimulating factor receptor in patients with severe congenital neutropenia. Blood. 2000;96:4366-4369.
13. Aprikyan AA, Carlsson G, Stein S, et al. Apoptosis of bone marrow progenitor cells and neutrophil elastase mutations in the original Kostmann families [abstract]. Blood. 2001;98:440a.
14. Aprikyan AA, Liles WC, Rodger E, Jonas M, Chi EY, Dale DC. Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia. Blood. 2001;97:147-153.
15. Dror Y, Freedman MH, Shwachman-Diamond syndrome: An inherited preleukemic bone marrow failure disorder with aberrant hematopoietic progenitors and faulty marrow microenvironment. Blood. 1999;94:3048-3054.
16. Dror Y, Freedman MH. Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway. Blood. 2001;97:3011-3016.
17. Dong F, Hoefsloot LH, Schelen AM, et al. Identification of a nonsense mutation in the granulocytecolony-stimulating factor receptor in severe congenital neutropenia. Proc Natl Acad Sci U S A. 1994;91:4480-4484.
18. Dong F, Brynes RK, Tidow N, Welte K, Lowenberg B, Touw IP. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia [see comments]. N Engl J Med. 1995;333:487-493.
19. Dong F, Dale DC, Bonilla MA, et al. Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia. 1997;11:120-125.
20. Sandoval C, Parganas E, Wang W, Ihle JN. Lack of alterations in the cytoplasmic domains of the granulocyte colony-stimulating factor receptors in eight cases of severe congenital neutropenia. Blood. 1995;85:852-860.
21. Germeshausen M, Jakobs S, Zeidler C, Welte K. Update on the G-CSF receptor gene mutations in patients with severe congenital neutropenia [abstract]. Blood, 2001;98:441a.
22. Tidow N, Pilz C, Teichmann B, et al. Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Blood. 1997;89:2369-2375.
23. Hermans MH, Ward AC, Antonissen C, Karis A, Lowenberg B, Touw IP. Perturbed granulopolesis in mice with a targeted mutation in the granulocyte colony-stimulating factor receptor gene associated with severe chronic neutropenia. Blood. 1998;92:32-39.
24. Hermans MH, Antonissen C, Ward AC, Mayen AE, Ploemacher RE, Touw IP. Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene. J Exp Med. 1999;189:683-692.
25. McLemore ML, Poursine-Laurent J, Link DC. Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia. J Clin Invest. 1998;102:483-492.
26. Horwitz M, Benson KF, Person RE, Aprikyan AG, Dale DC. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet. 1999;23:433-436.
27. Ancliff PJ, Gale RE, Liesner R, Hann IM, Linch DC. Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. Blood. 2001;98:2645-2650.
28. Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood. 2000;96: 2317-2322.
29. Aprikyan AA, Dale DC. Mutations in the neutrophil elastase gene in cyclic and congenital neutropenia. Curr Opin Immunol. 2001;13:535-538.
30. Ancliff PJ, Gale RE, Hann IM, Strobel S, Linch DC. Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia [abstract]. Blood. 2001;98:439a.
31. Srikanth S, Rado TA. A 30-base pair element is responsible for the myeloid-specific activity of the human neutrophil elastase promoter. J Biol Chem. 1994;269:32626-32633.
32. Adkison AM, Raptis SZ, Kelley DG, Pham CT. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J Clin Invest. 2002;109:363-371.
33. Belaaouaj A, McCarthy R, Baumann M, et al. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med. 1998;4:615-618.
34. MacIvor DM, Shapiro SD, Pham CT, Belaaouaj A, Abraham SN, Ley TJ. Normal neutrophil function in cathepsin G-deficient mice. Blood. 1999;94: 4282-4293.
35. Tkalcevic J, Novelli M, Phylactides M, Iredale JP, Segal AW, Roes J. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity. 2000;12:201-210.
36. Hug BA, Wesselschmidt RL, Fiering S, et al. Analysis of mice containing a targeted deletion of beta-globin locus control region 5′ hypersensitive site 3. Mol Cell Biol. 1996;16:2906-2912.
37. Nakajima K, Powers JC, Ashe BM, Zimmerman M. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site. J Biol Chem. 1979;254:4027-4032.
38. Lowell CA, Fumagalli L, Berton G. Deficiency of Src family kinases p59/61hck and p58c-fgr results in defective adhesion-dependent neutrophil functions. J Cell Biol. 1996;133:895-910.
39. Pham CT, MacIvor DM, Hug BA, Heusel JW, Ley TJ. Long-range disruption of gene expression by a selectable marker cassette. Proc Natl Acad Sci U S A. 1996;93:13090-13095.
40. Li FQ, Horwitz M. Characterization of mutant neutrophil elastase in severe congenital neutropenia. J Biol Chem. 2001;276:14230-14241.
41. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood. 1992;80:2012-2020.
42. Liu F, Poursine-Laurent J, Link DC. The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not flt-3 ligand. Blood. 1997;90:2522-2528.
43. Turk V, Turk B, Turk D. Lysosomal cysteine proteases: Facts and opportunities. EMBO J. 2001;20:4629-4633.
44. Pham CT, Ley TJ. Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc Natl Acad Sci U S A. 1999;96:8627-8632.
45. Toomes C, James J, Wood AJ, et al. Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet. 1999;23:421-424.
46. Belaaouaj A, Walsh BC, Jenkins NA, Copeland NG, Shapiro SD. Characterization of the mouse neutrophil elastase gene and localization to chromosome 10. Mamm Genome. 1997;8:5-8.
47. Lehrer RI, Ganz T. Defensins of vertebrate animals. Curr Opin Immunol. 2002;14:96-102.
48. Chen M, Tomkins DJ, Auerbach W, et al. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat Genet. 1996;12:448-451.
49. Cheng NC, van de Vrugt HJ, van der Valk MA, et al. Mice with a targeted disruption of the Fanconi anemia homolog Fanca. Hum Mol Genet. 2000;9: 1805-1811.
50. Yang Y, Kuang Y, De Oca RM, et al. Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. Blood. 2001;98:3435-3440.
51. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 1995;83: 993-1000.
52. Zimmer M, Medcalf RL, Fink TM, Mattmann C, Lichter P, Jenne DE. Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter. Proc Natl Acad Sci U S A. 1992;89:8215-8219.
53. Wong ET, Jenne DE, Zimmer M, Porter SD, Gilks CB. Changes in chromatin organization at the neutrophil elastase locus associated with myeloid cell differentiation. Blood. 1999;94:3730-3736.